trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Neurodegenerative Diseases D019636 32 associated lipids
Retinal Neoplasms D019572 3 associated lipids
Roseolovirus Infections D019349 1 associated lipids
Porcine Reproductive and Respiratory Syndrome D019318 4 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Thyroid Hormone Resistance Syndrome D018382 1 associated lipids
Neuroendocrine Tumors D018358 4 associated lipids
Rhabdoid Tumor D018335 1 associated lipids
Cystadenoma, Serous D018293 1 associated lipids
Cystadenocarcinoma, Serous D018284 2 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Kim SY et al. Glial cell-specific regulation of the JC virus early promoter by histone deacetylase inhibitors. 2003 J. Virol. pmid:12610114
Wang S and Zhu J Evidence for a relief of repression mechanism for activation of the human telomerase reverse transcriptase promoter. 2003 J. Biol. Chem. pmid:12611896
Shaker S et al. Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells. 2003 Leuk. Res. pmid:12620295
Dogra SC et al. Evidence that the coactivator CBP/p300 is important for phenobarbital-induced but not basal expression of the CYP2H1 gene. 2003 Mol. Pharmacol. pmid:12488538
Lietz M et al. RE-1 silencing transcription factor (REST) regulates human synaptophysin gene transcription through an intronic sequence-specific DNA-binding site. 2003 Eur. J. Biochem. pmid:12492469
Yamashita Y et al. Histone deacetylase inhibitor trichostatin A induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells. 2003 Int. J. Cancer pmid:12494463
Parekh-Olmedo H et al. The effect of hydroxyurea and trichostatin a on targeted nucleotide exchange in yeast and Mammalian cells. 2003 Ann. N. Y. Acad. Sci. pmid:14751821
McGhee L et al. Gfi-1 attaches to the nuclear matrix, associates with ETO (MTG8) and histone deacetylase proteins, and represses transcription using a TSA-sensitive mechanism. 2003 J. Cell. Biochem. pmid:12874834
Chun AC and Jin DY Transcriptional regulation of mitotic checkpoint gene MAD1 by p53. 2003 J. Biol. Chem. pmid:12876282
Grisolano JL et al. An activated receptor tyrosine kinase, TEL/PDGFbetaR, cooperates with AML1/ETO to induce acute myeloid leukemia in mice. 2003 Proc. Natl. Acad. Sci. U.S.A. pmid:12881486
Konduri SD et al. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells. 2003 Oncogene pmid:12881707
Nakajima M et al. Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expressions of the human CYP1 family in MCF-7 and HeLa cells. 2003 Toxicol. Lett. pmid:12927368
Papeleu P et al. Trichostatin A induces differential cell cycle arrests but does not induce apoptosis in primary cultures of mitogen-stimulated rat hepatocytes. 2003 J. Hepatol. pmid:12927923
Senawong T et al. Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression. 2003 J. Biol. Chem. pmid:12930829
Mulholland NM et al. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation. 2003 Oncogene pmid:12894222
Banwell CM et al. Antiproliferative signalling by 1,25(OH)2D3 in prostate and breast cancer is suppressed by a mechanism involving histone deacetylation. 2003 Recent Results Cancer Res. pmid:12899515
Yan Y et al. Analysis of specific lysine histone H3 and H4 acetylation and methylation status in clones of cells with a gene silenced by nickel exposure. 2003 Toxicol. Appl. Pharmacol. pmid:12902198
Augenlicht L et al. Repression of MUC2 gene expression by butyrate, a physiological regulator of intestinal cell maturation. 2003 Oncogene pmid:12902981
Hejnar J et al. Demethylation of host-cell DNA at the site of avian retrovirus integration. 2003 Biochem. Biophys. Res. Commun. pmid:14623319
Margueron R et al. Oestrogen receptor alpha increases p21(WAF1/CIP1) gene expression and the antiproliferative activity of histone deacetylase inhibitors in human breast cancer cells. 2003 J. Endocrinol. pmid:14529564
Thomas RM et al. Regulation of mouse mammary tumor virus env transcriptional activator initiated mammary tumor virus superantigen transcripts in lymphomas of SJL/J mice: role of Ikaros, demethylation, and chromatin structural change in the transcriptional activation of mammary tumor virus superantigen. 2003 J. Immunol. pmid:12496403
Adam E et al. Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha. 2003 Mol. Cell. Biol. pmid:12917341
Witt O et al. Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin. 2003 Blood pmid:12393499
Yang L et al. An ERG (ets-related gene)-associated histone methyltransferase interacts with histone deacetylases 1/2 and transcription co-repressors mSin3A/B. 2003 Biochem. J. pmid:12398767
Klisovic DD et al. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines. 2003 Invest. Ophthalmol. Vis. Sci. pmid:12766035
Génin P et al. Impairment of interferon-induced IRF-7 gene expression due to inhibition of ISGF3 formation by trichostatin A. 2003 J. Virol. pmid:12768031
Bartoli A et al. Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells. 2003 Pharmacol. Res. pmid:12770523
Koeller KM et al. Chemical genetic modifier screens: small molecule trichostatin suppressors as probes of intracellular histone and tubulin acetylation. 2003 Chem. Biol. pmid:12770822
Agoulnik IU et al. Repressors of androgen and progesterone receptor action. 2003 J. Biol. Chem. pmid:12771131
Huang Y et al. Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma. 2003 Int. J. Cancer pmid:12640681
Chung YL et al. A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis. 2003 Mol. Ther. pmid:14599803
Lu F et al. Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. 2003 J. Virol. pmid:14557628
Siddiqui H et al. Histone deacetylation of RB-responsive promoters: requisite for specific gene repression but dispensable for cell cycle inhibition. 2003 Mol. Cell. Biol. pmid:14560017
Martin D et al. Critical role of the transcriptional repressor neuron-restrictive silencer factor in the specific control of connexin36 in insulin-producing cell lines. 2003 J. Biol. Chem. pmid:14565956
Wong JE et al. Therapeutic strategies in gastric cancer. 2003 J. Clin. Oncol. pmid:14645406
Suzuki M et al. Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression. 2003 Oncogene pmid:14647463
Kim HS et al. Regulation of the tyrosine hydroxylase gene promoter by histone deacetylase inhibitors. 2003 Biochem. Biophys. Res. Commun. pmid:14651963
Coombes MM et al. Resetting the histone code at CDKN2A in HNSCC by inhibition of DNA methylation. 2003 Oncogene pmid:14654786
Marshall S et al. Enhanced expression of uridine diphosphate-N-acetylglucosaminyl transferase (OGT) in a stable, tetracycline-inducible HeLa cell line using histone deacetylase inhibitors: kinetics of cytosolic OGT accumulation and nuclear translocation. 2003 Anal. Biochem. pmid:12871726
Chan AS et al. Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma. 2003 Oncogene pmid:14534543
Allison SJ and Milner J Loss of p53 has site-specific effects on histone H3 modification, including serine 10 phosphorylation important for maintenance of ploidy. 2003 Cancer Res. pmid:14583461
Yamada Y et al. Aberrant methylation of the vascular endothelial growth factor receptor-1 gene in prostate cancer. 2003 Cancer Sci. pmid:12824880
Shi W et al. Induction of a senescent-like phenotype does not confer the ability of bovine immortal cells to support the development of nuclear transfer embryos. 2003 Biol. Reprod. pmid:12646489
Murumägi A et al. Characterization of regulatory elements and methylation pattern of the autoimmune regulator (AIRE) promoter. 2003 J. Biol. Chem. pmid:12651856
Kang J et al. Nickel-induced histone hypoacetylation: the role of reactive oxygen species. 2003 Toxicol. Sci. pmid:12773760
Maatouk DM and Resnick JL Continuing primordial germ cell differentiation in the mouse embryo is a cell-intrinsic program sensitive to DNA methylation. 2003 Dev. Biol. pmid:12781693
Ju R and Muller MT Histone deacetylase inhibitors activate p21(WAF1) expression via ATM. 2003 Cancer Res. pmid:12782595
Chua YL et al. The transcriptional enhancer of the pea plastocyanin gene associates with the nuclear matrix and regulates gene expression through histone acetylation. 2003 Plant Cell pmid:12782737
Cecconi D et al. Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A. 2003 Electrophoresis pmid:12783462
Fukuoka M et al. Negative regulation of forkhead transcription factor AFX (Foxo4) by CBP-induced acetylation. 2003 Int. J. Mol. Med. pmid:12964026
Vanommeslaeghe K et al. Ab initio study of the binding of Trichostatin A (TSA) in the active site of histone deacetylase like protein (HDLP). 2003 Org. Biomol. Chem. pmid:12968347
Huang H et al. [HDAC1 expression and effect of TSA on proliferation and apoptosis of A549 cells]. 2003 Ai Zheng pmid:12969522
Ohike N et al. Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas. 2003 Cancer Lett. pmid:12969792
Fass DM et al. Deacetylase activity is required for cAMP activation of a subset of CREB target genes. 2003 J. Biol. Chem. pmid:12939274
Zhao C et al. A composite motif of the Drosophila morphogenetic protein bicoid critical to transcription control. 2003 J. Biol. Chem. pmid:12939280
Yasui W et al. Histone acetylation and gastrointestinal carcinogenesis. 2003 Ann. N. Y. Acad. Sci. pmid:12724227
Jedrusik MA and Schulze E Telomeric position effect variegation in Saccharomyces cerevisiae by Caenorhabditis elegans linker histones suggests a mechanistic connection between germ line and telomeric silencing. 2003 Mol. Cell. Biol. pmid:12724425
Vos MD et al. The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lung. 2003 J. Biol. Chem. pmid:12676952
Detich N et al. The methyl donor S-Adenosylmethionine inhibits active demethylation of DNA: a candidate novel mechanism for the pharmacological effects of S-Adenosylmethionine. 2003 J. Biol. Chem. pmid:12676953
Foubister V Anticancer drug shows promise against lupus. 2003 Drug Discov. Today pmid:12681930
Park WH et al. Trichostatin inhibits the growth of ACHN renal cell carcinoma cells via cell cycle arrest in association with p27, or apoptosis. 2003 Int. J. Oncol. pmid:12684681
Farhan H et al. Genistein inhibits vitamin D hydroxylases CYP24 and CYP27B1 expression in prostate cells. 2003 J. Steroid Biochem. Mol. Biol. pmid:12732287
Chambers AE et al. Histone acetylation-mediated regulation of genes in leukaemic cells. 2003 Eur. J. Cancer pmid:12736119
Hoever G et al. The mechanism of 3'-azido-2',3'-dideoxythymidine resistance to human lymphoid cells. 2003 Int. J. Mol. Med. pmid:12736716
Valenta T et al. HMG box transcription factor TCF-4's interaction with CtBP1 controls the expression of the Wnt target Axin2/Conductin in human embryonic kidney cells. 2003 Nucleic Acids Res. pmid:12711682
Arora T et al. PIASx is a transcriptional co-repressor of signal transducer and activator of transcription 4. 2003 J. Biol. Chem. pmid:12716907
Sonoyama K et al. Upregulation of activin A gene by butyrate in human colon cancer cell lines. 2003 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:12540370
Noss KR et al. Methylation state of the prostate specific membrane antigen (PSMA) CpG island in prostate cancer cell lines. 2002 May-Jun Anticancer Res. pmid:12168830
Rahman I et al. Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. 2002 May-Jun Mol. Cell. Biochem. pmid:12162440
Iwata K et al. Trichostatin A, a histone deacetylase inhibitor, down-regulates interleukin-12 transcription in SV-40-transformed lung epithelial cells. 2002 Jul-Aug Cell. Immunol. pmid:12470611
Sourlingas TG et al. The effect of the histone deacetylase inhibitor, trichostatin A, on total histone synthesis, H1(0) synthesis and histone H4 acetylation in peripheral blood lymphocytes increases as a function of increasing age: a model study. 2002 Jan-Mar Exp. Gerontol. pmid:11772521
Sanyal S et al. Differential regulation of the orphan nuclear receptor small heterodimer partner (SHP) gene promoter by orphan nuclear receptor ERR isoforms. 2002 J. Biol. Chem. pmid:11705994
Guo WH et al. Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor. 2002 Oncogene pmid:12447699
Marin-Husstege M et al. Histone deacetylase activity is necessary for oligodendrocyte lineage progression. 2002 J. Neurosci. pmid:12451133
Wang ZM et al. Trichostatin A inhibits proliferation and induces expression of p21WAF and p27 in human brain tumor cell lines. 2002 Ai Zheng pmid:12508652
Duharcourt S and Yao MC Role of histone deacetylation in developmentally programmed DNA rearrangements in Tetrahymena thermophila. 2002 Eukaryotic Cell pmid:12455963
Strait KA et al. Cell cycle blockade and differentiation of ovarian cancer cells by the histone deacetylase inhibitor trichostatin A are associated with changes in p21, Rb, and Id proteins. 2002 Mol. Cancer Ther. pmid:12479699
Blagosklonny MV et al. Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity. 2002 Mol. Cancer Ther. pmid:12481415
Kishikawa S et al. Roles of histone acetylation in the Dnmt1 gene expression. 2002 Nucleic Acids Res. Suppl. pmid:12903179
Ginjala V et al. Multiple cis elements within the Igf2/H19 insulator domain organize a distance-dependent silencer. A cautionary note. 2002 J. Biol. Chem. pmid:11777900
Cabral AL et al. Regulation of the cellular prion protein gene expression depends on chromatin conformation. 2002 J. Biol. Chem. pmid:11739375
Park SH et al. Transcriptional regulation of the transforming growth factor beta type II receptor gene by histone acetyltransferase and deacetylase is mediated by NF-Y in human breast cancer cells. 2002 J. Biol. Chem. pmid:11744689
Suenaga M et al. Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells. 2002 Int. J. Cancer pmid:11807787
Gurova KV et al. Expression of prostate specific antigen (PSA) is negatively regulated by p53. 2002 Oncogene pmid:11791186
Aapola U et al. Imprinting regulator DNMT3L is a transcriptional repressor associated with histone deacetylase activity. 2002 Nucleic Acids Res. pmid:12177302
Chang TH and Szabo E Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung. 2002 Clin. Cancer Res. pmid:11948134
Ventura A et al. The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter. 2002 J. Biol. Chem. pmid:11948181
Gradoville L et al. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle. 2002 J. Virol. pmid:11991990
Uesato S et al. Novel histone deacetylase inhibitors: N-hydroxycarboxamides possessing a terminal bicyclic aryl group. 2002 Bioorg. Med. Chem. Lett. pmid:11992774
Nambiar MP et al. Effect of trichostatin A on human T cells resembles signaling abnormalities in T cells of patients with systemic lupus erythematosus: a new mechanism for TCR zeta chain deficiency and abnormal signaling. 2002 J. Cell. Biochem. pmid:11967985
Fu M et al. Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function. 2002 Mol. Cell. Biol. pmid:11971970
Sirchia SM et al. Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer. 2002 Cancer Res. pmid:11980632
Woo SH et al. Structurally simple trichostatin A-like straight chain hydroxamates as potent histone deacetylase inhibitors. 2002 J. Med. Chem. pmid:12061890
Chen Y et al. On the epigenetic regulation of the human reelin promoter. 2002 Nucleic Acids Res. pmid:12087179
Zhang Y and Dufau ML Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex. 2002 J. Biol. Chem. pmid:12091390
Danbara M et al. DNA methylation dominates transcriptional silencing of Pax5 in terminally differentiated B cell lines. 2002 Mol. Immunol. pmid:12044782
Lin HM et al. Cyclin D1 Is a Ligand-independent Co-repressor for Thyroid Hormone Receptors. 2002 J. Biol. Chem. pmid:12048199
Quivy V et al. Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies. 2002 J. Virol. pmid:12368351
Smith WL and Edlind TD Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation. 2002 Antimicrob. Agents Chemother. pmid:12384361
Harada K et al. Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. 2002 Cancer Res. pmid:12384554